Practice patterns for extended venous thromboembolism chemoprophylaxis among urologic oncologists after radical cystectomy.
CONCLUSIONS: The majority of surveyed urologic oncologists are prescribing subcutaneous enoxaparin ECP following RC. Poor patient adherence due to self-injections and financial barriers were frequently reported and represent a possible opportunity for the use of oral anticoagulants in the post-operative setting. These data will be used in the development of a proposed clinical trial of a DOAC in the post-RC setting.
PMID: 32616422 [PubMed - as supplied by publisher]
Source: Urologic Oncology - Category: Urology & Nephrology Authors: Dall CP, Shaw N, Egan J, Carvalho FL, Galloway LAS, Krasnow R, Stamatakis L Tags: Urol Oncol Source Type: research
More News: Academia | Bladder Cancer | Cancer | Cancer & Oncology | Clinical Trials | Coumadin | Insurance | Lovenox | Oral Cancer | Orthopaedics | Thrombosis | Urology & Nephrology | Warfarin